Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
David P. Nicolau, PharmD
Director
Hartford Hospital
Poster(s):
(2121)
In vitro
Synergy of the Combination of Sulbactam-Durlobactam and Cefepime at Clinically Relevant Concentrations Against
A. baumannii
,
P. aeruginosa
, and Enterobacterales
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2125) Activity of Novel β-Lactam/β-Lactamase Inhibitor Combinations against Serine-Carbapenemase
producing
Carbapenem-Resistant
Pseudomonas
aeruginosa
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2165)
Assessing the Impact of Meropenem Exposure on Ceftolozane/tazobactam-resistance Development in
Pseudomonas aeruginosa
using
in vitro
Serial Passage
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2526)
Ex Vivo
Assessment of Sulbactam-Durlobactam (SUL-DUR) Clearance during Continuous Renal Replacement Therapy (CRRT)
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
(2798) Difficult to treat GES and KPC harboring
Pseudomonas aeruginosa
: Evaluation of
in vivo
efficacy of ß-lactam/ß-lactamase inhibitor humanized exposure vs.
in vitro
efficacy
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
